Fig. 6.
Illustration of SDT synergistically enhances the efficacy of immune system modulators by TLRs and STING-agonists. a) Scheme of antitumor immune responses induced by combined SDT with TLRs R837 and αPD-L1. Reprinted with permission from Ref. [13]. Copyright 2022, Springer Nature. b) Scheme of mechanism for iSDT enhanced by HMME@BiL with STING-agonists. Reprinted with permission from Ref. [148]. Copyright 2022, Wiley-VCH. c) Synthesis of PSPA and its mechanisms to synergistically enhance immunotherapy. Reprinted with permission from Ref. [149]. Copyright 2023, Wiley-VCH.